JBC Transcription and Nuclear Factor Monoclonals

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M000932200 on May 4, 2000

J. Biol. Chem., Vol. 275, Issue 30, 23387-23397, July 28, 2000
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
275/30/23387    most recent
M000932200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ambrosetti, D.-C.
Right arrow Articles by Basilico, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ambrosetti, D.-C.
Right arrow Articles by Basilico, C.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Modulation of the Activity of Multiple Transcriptional Activation Domains by the DNA Binding Domains Mediates the Synergistic Action of Sox2 and Oct-3 on the Fibroblast Growth Factor-4 Enhancer*

Davide-Carlo AmbrosettiDagger §, Hans R. Schöler, Lisa DaileyDagger ||, and Claudio BasilicoDagger **

From the Dagger  Department of Microbiology, New York University School of Medicine, New York, New York 10016 and the  Center for Animal Transgenesis and Germ Cell Research, New Bolton Center, University of Pennsylvania, Kennett Square, Pennsylvania 19348

Fibroblast growth factor (FGF)-4 gene expression in the inner cell mass of the blastocyst and in EC cells requires the combined activity of two transcriptional regulators, Sox2 and Oct-3, which bind to adjacent sites on the FGF-4 enhancer DNA and synergistically activate transcription. Sox2 and Oct-3 bind cooperatively to the enhancer DNA through their DNA-binding, high mobility group and POU domains, respectively. These two domains, however, are not sufficient to activate transcription. We have analyzed a number of Sox2 and Oct-3 deletion mutants to identify the domains within each protein that contribute to the activity of the Sox2·Oct-3 complex. Within Oct-3, we have identified two activation domains, the N-terminal AD1 and the C-terminal AD2, that play a role in the activity of the Sox2·Oct-3 complex. AD1 also displays transcriptional activation functions in the absence of Sox2 while AD2 function was only detected within the Sox2·Oct-3 complex. In Sox2, we have identified three activation domains within its C terminus: R1, R2, and R3. R1 and R2 can potentiate weak activation by Sox2 in the absence of Oct-3 but their deletion has no effect on the Sox2·Oct-3 complex. In contrast, R3 function is only observed when Sox2 is complexed with Oct-3. In addition, analysis of Oct-1/Oct-3 chimeras indicates that the Oct-3 homeodomain also plays a critical role in the formation of a functional Sox2·Oct-3 complex. Our results are consistent with a model in which the synergistic action of Sox2 and Oct-3 results from two major processes. Cooperative binding of the factors to the enhancer DNA, mediated by their binding domains, stably tethers each factor to DNA and increases the activity of intrinsic activation domains within each protein. Protein-protein and protein-DNA interactions then may lead to reciprocal conformational changes that expose latent activation domains within each protein. These findings define a mechanism that may also be utilized by other Sox·POU protein complexes in gene activation.


* This work was supported by United States Public Health Service Grants CA42568 and CA78925 from the National Cancer Institute.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

§ Present address: Universita degli Studi di Bologna, Dipartimento di Biologia, Evoluzionistica Sperimentale, 53100 Bologna, Italy.

|| To whom correspondence may be addressed. Tel.: 212-263-0525; Fax: 212-263-8714; E-mail: dailel01@med.nyu.edu.

** To whom correspondence may be addressed. Tel.: 212-263-5341; Fax: 212-263-8714; E-mail: basilc01@med.nyu.edu.


Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
ReproductionHome page
S J Kimber, S F Sneddon, D J Bloor, A M El-Bareg, J A Hawkhead, A D Metcalfe, F D Houghton, H J Leese, A Rutherford, B A Lieberman, et al.
Expression of genes involved in early cell fate decisions in human embryos and their regulation by growth factors
Reproduction, May 1, 2008; 135(5): 635 - 647.
[Abstract] [Full Text] [PDF]


Home page
GeneticsHome page
P. Estes, E. Fulkerson, and Y. Zhang
Identification of Motifs That Are Conserved in 12 Drosophila Species and Regulate Midline Glia vs. Neuron Expression
Genetics, February 1, 2008; 178(2): 787 - 799.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
B. Boer, J. Kopp, S. Mallanna, M. Desler, H. Chakravarthy, P. J. Wilder, C. Bernadt, and A. Rizzino
Elevating the levels of Sox2 in embryonal carcinoma cells and embryonic stem cells inhibits the expression of Sox2:Oct-3/4 target genes
Nucleic Acids Res., March 27, 2007; (2007) gkm059v2.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
J.-L. Chew, Y.-H. Loh, W. Zhang, X. Chen, W.-L. Tam, L.-S. Yeap, P. Li, Y.-S. Ang, B. Lim, P. Robson, et al.
Reciprocal Transcriptional Regulation of Pou5f1 and Sox2 via the Oct4/Sox2 Complex in Embryonic Stem Cells
Mol. Cell. Biol., July 15, 2005; 25(14): 6031 - 6046.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Biol.Home page
A. Mansukhani, D. Ambrosetti, G. Holmes, L. Cornivelli, and C. Basilico
Sox2 induction by FGF and FGFR2 activating mutations inhibits Wnt signaling and osteoblast differentiation
J. Cell Biol., March 28, 2005; 168(7): 1065 - 1076.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Okumura-Nakanishi, M. Saito, H. Niwa, and F. Ishikawa
Oct-3/4 and Sox2 Regulate Oct-3/4 Gene in Embryonic Stem Cells
J. Biol. Chem., February 18, 2005; 280(7): 5307 - 5317.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
N. Rajaram and T. K. Kerppola
Synergistic Transcription Activation by Maf and Sox and Their Subnuclear Localization Are Disrupted by a Mutation in Maf That Causes Cataract
Mol. Cell. Biol., July 1, 2004; 24(13): 5694 - 5709.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. C. Williams Jr., M. Cai, and G. M. Clore
Molecular Basis for Synergistic Transcriptional Activation by Oct1 and Sox2 Revealed from the Solution Structure of the 42-kDa Oct1{middle dot}Sox2{middle dot}Hoxb1-DNA Ternary Transcription Factor Complex
J. Biol. Chem., January 9, 2004; 279(2): 1449 - 1457.
[Abstract] [Full Text] [PDF]


Home page
Genes Dev.Home page
A. Remenyi, K. Lins, L. J. Nissen, R. Reinbold, H. R. Scholer, and M. Wilmanns
Crystal structure of a POU/HMG/DNA ternary complex suggests differential assembly of Oct4 and Sox2 on two enhancers
Genes & Dev., August 15, 2003; 17(16): 2048 - 2059.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. S. Wiebe, T. K. Nowling, and A. Rizzino
Identification of Novel Domains within Sox-2 and Sox-11 Involved in Autoinhibition of DNA Binding and Partnership Specificity
J. Biol. Chem., May 9, 2003; 278(20): 17901 - 17911.
[Abstract] [Full Text] [PDF]


Home page
Genes Dev.Home page
A. A. Avilion, S. K. Nicolis, L. H. Pevny, L. Perez, N. Vivian, and R. Lovell-Badge
Multipotent cell lineages in early mouse development depend on SOX2 function
Genes & Dev., January 1, 2003; 17(1): 126 - 140.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
M. Tomioka, M. Nishimoto, S. Miyagi, T. Katayanagi, N. Fukui, H. Niwa, M. Muramatsu, and A. Okuda
Identification of Sox-2 regulatory region which is under the control of Oct-3/4-Sox-2 complex
Nucleic Acids Res., July 15, 2002; 30(14): 3202 - 3213.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Terraz, G. Brideau, P. Ronco, and J. Rossert
A Combination of cis-Acting Elements Is Required to Activate the Pro-alpha 1(I) Collagen Promoter in Tendon Fibroblasts of Transgenic Mice
J. Biol. Chem., May 17, 2002; 277(21): 19019 - 19026.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
H. Niwa, S. Masui, I. Chambers, A. G. Smith, and J.-i. Miyazaki
Phenotypic Complementation Establishes Requirements for Specific POU Domain and Generic Transactivation Function of Oct-3/4 in Embryonic Stem Cells
Mol. Cell. Biol., March 1, 2002; 22(5): 1526 - 1536.
[Abstract] [Full Text] [PDF]


Home page
Stem CellsHome page
M. Pesce and H. R. Scholer
Oct-4: Gatekeeper in the Beginnings of Mammalian Development
Stem Cells, July 1, 2001; 19(4): 271 - 278.
[Abstract] [Full Text] [PDF]


Home page
Genes Dev.Home page
Y. Kamachi, M. Uchikawa, A. Tanouchi, R. Sekido, and H. Kondoh
Pax6 and SOX2 form a co-DNA-binding partner complex that regulates initiation of lens development
Genes & Dev., May 15, 2001; 15(10): 1272 - 1286.
[Abstract] [Full Text]


Home page
Mol. Endocrinol.Home page
M. A. Weiss
Floppy SOX: Mutual Induced Fit in HMG (High-Mobility Group) Box-DNA Recognition
Mol. Endocrinol., March 1, 2001; 15(3): 353 - 362.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2000 by the American Society for Biochemistry and Molecular Biology.